Economiic Home Method Watch Market RSI Search

BiomX Inc. PHGE

Sector:

Healthcare

Industry:

Biotechnology

Description:

BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC). It is developing BX004, a phage therapy for CF patients with chronic Pseudomonas aeruginosa respiratory infections that is in Phase 1b/2a clinical trials. The company's pipeline products also include BX005, a topical phage cocktail, which is in Phase 1/2 clinical study that targets Staphylococcus aureus (S. aureus), a bacteria associated with the manifestation of the disease; and BX003, an orally administered phage cocktail, which is in Phase 1b/2a that targets a bacterial target present in the gut of IBD and PSC patients. In addition, the company engages in the provision of colorectal cancer program that utilizes engineered phage with various payloads, which are administered intravenously to target Fusobacterium nucleatum bacteria residing within the tumor microenvironment. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.
BiomX Inc. website

Recent Quarter:

2024-11-12

Upcoming Quarter:

2025-04-01

Annual Reports

Date2024-04-04
Revenue -357,000
Net Income -26,169,000
EPS -5.1
Basic Shares 5,133,032
Diluted Shares 5,133,032
Report Link
Date2023-03-29
Revenue -134,000
Net Income -28,317,000
EPS -9.49
Basic Shares 2,985,400
Diluted Shares 2,985,400
Report Link
Date2022-03-30
Revenue 0
Net Income -36,226,000
EPS -13.93
Basic Shares 2,600,794
Diluted Shares 2,600,794
Report Link
Date2021-03-31
Revenue 0
Net Income -29,914,000
EPS -12.97
Basic Shares 2,306,221
Diluted Shares 2,306,221
Report Link
Date2020-03-26
Revenue 0
Net Income -18,919,000
EPS -8.36
Basic Shares 2,263,020
Diluted Shares 2,263,020
Report Link
Date2018-12-31
Revenue 0
Net Income -12,945,000
EPS -6.46
Basic Shares 2,002,463
Diluted Shares 2,002,464
Report Link
Date2017-12-31
Revenue 0
Net Income -6,433,000
EPS -3.27
Basic Shares 1,967,669
Diluted Shares 1,967,669
Report Link

Annual Ratios

Date2023-12-31
PE -0.55
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-12-31
PE -0.20
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-12-31
PE -1.15
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-12-31
PE -4.92
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-12-31
PE -11.58
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-06-30
PE -15.16
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-06-30
PE -29.52
Dividend Yield 0.00
Payout Ratio: 0.000%

Quarterly Reports

Date2024-11-14
Revenue -84,000
Net Income -9,642,000
EPS 0.0003
Basic Shares 16,366,122,000
Diluted Shares 16,387,633,000
Report Link
Date2024-08-14
Revenue 0
Net Income 4,471,000
EPS 0.64
Basic Shares 6,980,942
Diluted Shares 10,750,193
Report Link
Date2024-05-20
Revenue -88,000
Net Income -17,327,000
EPS -2.78
Basic Shares 6,229,227
Diluted Shares 6,229,227
Report Link
Date2024-04-04
Revenue -87,000
Net Income -5,491,000
EPS -1.19
Basic Shares 4,597,993
Diluted Shares 4,597,993
Report Link
Date2023-11-14
Revenue -89,000
Net Income -382,000
EPS -0.063
Basic Shares 6,058,771
Diluted Shares 6,058,771
Report Link
Date2023-08-09
Revenue -90,000
Net Income -6,411,000
EPS -1.24
Basic Shares 5,155,292
Diluted Shares 5,155,292
Report Link
Date2023-05-15
Revenue -91,000
Net Income -6,361,000
EPS -1.98
Basic Shares 3,212,522
Diluted Shares 3,212,522
Report Link
Date2023-03-29
Revenue -134,000
Net Income -5,886,000
EPS -1.96
Basic Shares 2,997,658
Diluted Shares 2,997,658
Report Link
Date2022-11-09
Revenue -52,000
Net Income -6,780,000
EPS -2.27
Basic Shares 2,990,781
Diluted Shares 2,990,781
Report Link
Date2022-08-10
Revenue 0
Net Income -7,482,000
EPS -2.51
Basic Shares 2,977,470
Diluted Shares 2,977,470
Report Link
Date2022-05-11
Revenue 0
Net Income -8,169,000
EPS -2.75
Basic Shares 2,975,424
Diluted Shares 2,975,424
Report Link
Date2022-03-30
Revenue 0
Net Income -10,457,000
EPS -3.67
Basic Shares 2,848,950
Diluted Shares 2,848,950
Report Link
Date2021-11-15
Revenue 0
Net Income -10,011,000
EPS -3.7
Basic Shares 2,707,790
Diluted Shares 2,707,790
Report Link
Date2021-08-16
Revenue 0
Net Income -7,336,000
EPS -3.02
Basic Shares 2,432,025
Diluted Shares 2,432,025
Report Link
Date2021-05-24
Revenue 0
Net Income -8,402,000
EPS -3.51
Basic Shares 2,394,457
Diluted Shares 2,394,457
Report Link
Date2021-03-31
Revenue 0
Net Income -9,144,000
EPS -3.95
Basic Shares 2,317,389
Diluted Shares 2,317,389
Report Link
Date2020-11-12
Revenue 0
Net Income -8,835,000
EPS -3.82
Basic Shares 2,315,025
Diluted Shares 2,315,025
Report Link
Date2020-08-13
Revenue 0
Net Income -6,206,000
EPS -2.7
Basic Shares 2,296,907
Diluted Shares 2,296,907
Report Link
Date2020-05-14
Revenue 0
Net Income -5,901,000
EPS -2.58
Basic Shares 2,289,772
Diluted Shares 2,289,772
Report Link
Date2020-03-26
Revenue 0
Net Income -22,207,000
EPS -9.71
Basic Shares 2,286,283
Diluted Shares 2,286,283
Report Link
Date2019-10-16
Revenue 0
Net Income -292,179
EPS -0.13
Basic Shares 2,239,757
Diluted Shares 2,239,757
Report Link
Date2019-08-21
Revenue 0
Net Income 56,991
EPS 0.0254
Basic Shares 2,204,162
Diluted Shares 2,204,162
Report Link
Date2019-05-10
Revenue 0
Net Income 280,608
EPS 0.13
Basic Shares 2,210,914
Diluted Shares 2,210,914
Report Link
Date2019-02-06
Revenue 0
Net Income 10,458
EPS 0.0058
Basic Shares 2,204,162
Diluted Shares 2,204,162
Report Link
Date2018-09-30
Revenue 0
Net Income -650
EPS -0.0004
Basic Shares 1,815,004
Diluted Shares 1,815,004
Report Link
Date2018-03-31
Revenue 0
Net Income -1,000
EPS -0.0006
Basic Shares 1,815,004
Diluted Shares 1,815,004
Report Link

Quarterly Ratios

Date2024-09-30
PE -432.83
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2024-06-30
PE 1.33
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2024-03-31
PE -0.37
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-12-31
PE -0.59
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-09-30
PE -13.96
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-06-30
PE -0.72
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-03-31
PE -0.39
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-12-31
PE -0.24
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-09-30
PE -0.37
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-06-30
PE -0.73
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-03-31
PE -1.76
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-12-31
PE -1.09
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-09-30
PE -2.07
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-06-30
PE -4.53
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-03-31
PE -5.07
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-12-31
PE -4.04
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-09-30
PE -4.15
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-06-30
PE -5.11
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-03-31
PE -6.79
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-12-31
PE -2.49
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-09-30
PE -194.52
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-06-30
PE 947.55
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-03-31
PE 192.96
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-12-31
PE 5084.66
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-09-30
PE -67364.57
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-03-31
PE -43786.97
Dividend Yield 0.00
Payout Ratio: 0.000%

RSI:

13.43

Price:

$0.51

Market Cap:

9,251,889

EPS TTM:

-3.33

PE Ratio:

-297.63

PEPSG:

NaN

Fwd PE:

NaN

Volume:

93,460

2 Year Price Change

0.212

Index 2 Year Price Change

1.497

5 Year Price Change

0.007

Index 5 Year Price Change

1.905
PESPG: Growth Rate of EPS projected to next quarter and 6 months trailing. Lower is better to help calculate nexts quarters PE Ratio today. Diluted shares effects the EPS reported and makes calculation show as extremely poor expected growth.

Revenue

Net Income

EPS

Shares

News

Press Releases

Notable Earnings

Please select an option: